ALLADAPT IMMUNOTHERAPEUTICS

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being advanced as a broad spectrum oral immunotherapy treatment to mitigate food allergy triggered by single or multiple proteins from an expansive set of common allergens.

#SimilarOrganizations #People #Financial #Website #More

ALLADAPT IMMUNOTHERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology

Founded:

2018-01-01

Address:

Menlo Park, California, United States

Country:

United States

Website Url:

http://www.alladapt.com

Total Employee:

11+

Status:

Active

Total Funding:

229 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag ReCAPTCHA Cloudflare JS US Privacy User Signal Mechanism

Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

Current Advisors List

christopher-a-viehbacher_image

Christopher A. Viehbacher Board Member @ Alladapt Immunotherapeutics
Board_member
2020-02-01

sophie-kornowski_image

Sophie Kornowski Board Member @ Alladapt Immunotherapeutics
Board_member
2020-02-01

george-montgomery_image

George Montgomery Board Member @ Alladapt Immunotherapeutics
Board_member

not_available_image

Greg Horn Board Member @ Alladapt Immunotherapeutics
Board_member
2020-02-01

james-momtazee_image

James Momtazee Board Member @ Alladapt Immunotherapeutics
Board_member

Current Employees Featured

dana-mcclintock_image

Dana McClintock
Dana McClintock Chief Medical Officer @ Alladapt Immunotherapeutics
Chief Medical Officer

ashley-dombkowski_image

Ashley Dombkowski
Ashley Dombkowski CEO & Co-Founder @ Alladapt Immunotherapeutics
CEO & Co-Founder
2018-03-01

Founder

ashley-dombkowski_image

Ashley Dombkowski

not_available_image

Kari Nadeau

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Debt Financing - Alladapt Immunotherapeutics

westriver-group_image

WestRiver Group

WestRiver Group investment in Venture Round - Alladapt Immunotherapeutics

gurnet-point-capital_image

Gurnet Point Capital

Gurnet Point Capital investment in Venture Round - Alladapt Immunotherapeutics

novartis_image

Novartis

Novartis investment in Venture Round - Alladapt Immunotherapeutics

patient-square-capital_image

Patient Square Capital

Patient Square Capital investment in Venture Round - Alladapt Immunotherapeutics

red-tree-venture-capital_image

Red Tree Venture Capital

Red Tree Venture Capital investment in Venture Round - Alladapt Immunotherapeutics

allerfund_image

AllerFund

AllerFund investment in Venture Round - Alladapt Immunotherapeutics

trb-advisors_image

TRB Advisors

TRB Advisors investment in Series C - Alladapt Immunotherapeutics

jeff-weiner_image

Jeff Weiner

Jeff Weiner investment in Series C - Alladapt Immunotherapeutics

sacha-lainovic_image

Sacha Lainovic

Sacha Lainovic investment in Series C - Alladapt Immunotherapeutics

Official Site Inspections

http://www.alladapt.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.59 K

Host Informations
Whois Informations

Loading ...

More informations about "Alladapt Immunotherapeutics" on Search Engine